Trial Profile
Dose-finding and pharmacodynamic study of ticagrelor versus clopidogrel in patients with atherosclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Atherosclerosis; Embolism and thrombosis
- Focus Pharmacodynamics
- Acronyms DISPERSE
- 05 Nov 2010 New trial record.